BPS Bioscience Inc.
中级会员 | 第3年

当前位置:BPS Bioscience Inc.>>细胞库 / 细胞培养>> Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-CD3ζ)

Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-CD3ζ)

参  考  价面议
具体成交价以合同协议为准

产品型号

品       牌BPS Bioscience

厂商性质生产商

所  在  地

更新时间:2023-10-12 10:43:59浏览次数:184次

联系我时,请告知来自 化工仪器网
  • 数量:

    1

  • 供应商:

    BPS Bioscience

  • 细胞类型:

    稳转细胞系

  • 品系:

    Jurkat

  • 组织来源:

    /

  • 相关疾病:

    多种

  • 物种来源:

    human

  • 免疫类型:

    多种

  • 器官来源:

  • 运输方式:

    干冰

  • 年限:

    10

  • 生长状态:

    良好

  • CAS号:

  • 英文名:

    Anti-CD19 CAR / NFAT (Luciferase) Reporter Jurkat Cell Line (CD19 SCFV-CD28-4-1BB-CD3ζ)

  • 注册证号:

    /

  • 规格:

    2管

Anti-CD19 CAR/NFAT-luciferase reporter Jurkat cell line is a double stable cell line expressing anti-CD19 CAR and NFAT-luciferase reporter. It is made from the anti-CD19 CAR lentivirus (BPS Bioscience #79851). The reporter cell line has been validated for anti CD19-CAR expression by FACS, and for luciferase reporter activation stimulated by target cells including CD19/CHO recombinant cell line can be used for primary screening and functional validation of anti-CD19 CAR construct and lentivirus before testing in primary T cells.

Anti-CD19 CAR consists of anti-CD19 scFv linked to 3rd generation CAR (Chimeric Antigen Receptor) containing CD28, 4-1BB co-stimulatory domains, and CD3ζ signaling domain.

会员登录

×

请输入账号

请输入密码

=

请输验证码

收藏该商铺

X
该信息已收藏!
标签:
保存成功

(空格分隔,最多3个,单个标签最多10个字符)

常用:

提示

X
您的留言已提交成功!我们将在第一时间回复您~
拨打电话
在线留言